arylpiperazine derivatives (Guangzhou Medical University)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namearylpiperazine derivatives (Guangzhou Medical University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenoceptor Alpha 1D antagonistsAlpha-1a adrenergic receptor antagonists
TargetsAdrenoceptor Alpha 1DAlpha-1a adrenergic receptor
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesGuangzhou Medical University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGuangzhou Medical University
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A